Literature DB >> 2037382

Intramacrophage growth of Mycobacterium avium during infection of mice.

C Frehel1, C de Chastellier, C Offredo, P Berche.   

Abstract

Growth of the virulent Mycobacterium avium strain TMC 724 in host tissues during persistent infection of mice was studied. Following intravenous infection of C57BL/6 mice, the kinetics of bacterial growth was biphasic in the spleen and liver, with a significant reduction of the multiplication rate after day 21 to 28 of infection. An electron-microscopic study of the liver and spleen of infected mice showed that the bacteria were strictly intracellular. They were observed within inflammatory macrophages populating granulomas disseminated in host tissues. The bacteria were confined to the phagosome compartment, and they were encapsulated. Phagosome-lysosome fusions were encountered, but the bacteria showed no visible signs of degradation and continued to multiply. These results are the first in vivo evidence that virulent M. avium multiplies exclusively intracellularly and that encapsulated bacteria resist the microbicidal mechanisms of macrophages inside the phagosomal compartment.

Entities:  

Mesh:

Year:  1991        PMID: 2037382      PMCID: PMC257991          DOI: 10.1128/iai.59.6.2207-2214.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Binding of Mycobacterium avium-Mycobacterium intracellulare to human leukocytes.

Authors:  A Catanzaro; S D Wright
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

Review 2.  Opportunistic pathogens in the genus Mycobacterium.

Authors:  R C Good
Journal:  Annu Rev Microbiol       Date:  1985       Impact factor: 15.500

3.  Immune response to atypical mycobacteria: immunocompetence of heavily infected mice measured in vivo fails to substantiate immunosuppression data obtained in vitro.

Authors:  I M Orme; F M Collins
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

4.  Electron-transparent zone of mycobacteria may be a defence mechanism.

Authors:  P Draper; R J Rees
Journal:  Nature       Date:  1970-11-28       Impact factor: 49.962

5.  Resistance of various strains of mycobacteria to killing by activated macrophages in vivo.

Authors:  I M Orme; F M Collins
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

6.  Disseminated Mycobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency.

Authors:  P Zakowski; S Fligiel; G W Berlin; L Johnson
Journal:  JAMA       Date:  1982-12-10       Impact factor: 56.272

Review 7.  Autopsy pathology in the acquired immune deficiency syndrome.

Authors:  C M Reichert; T J O'Leary; D L Levens; C R Simrell; A M Macher
Journal:  Am J Pathol       Date:  1983-09       Impact factor: 4.307

8.  In vitro response of murine alveolar and peritoneal macrophages to Mycobacterium intracellulare.

Authors:  P R Gangadharam; P F Pratt
Journal:  Am Rev Respir Dis       Date:  1983-12

9.  Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium.

Authors:  C Frehel; C de Chastellier; T Lang; N Rastogi
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

10.  Crossprotection against nontuberculous mycobacterial infections by Mycobacterium tuberculosis memory immune T lymphocytes.

Authors:  I M Orme; F M Collins
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

View more
  9 in total

1.  High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis.

Authors:  Elisabeth Billard; Chantal Cazevieille; Jacques Dornand; Antoine Gross
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  The phagosomal environment protects virulent Mycobacterium avium from killing and destruction by clarithromycin.

Authors:  C Fréhel; C Offredo; C de Chastellier
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Pathogenic mycobacteria disrupt the macrophage actin filament network.

Authors:  I Guérin; C de Chastellier
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

4.  Implication of phagosome-lysosome fusion in restriction of Mycobacterium avium growth in bone marrow macrophages from genetically resistant mice.

Authors:  C de Chastellier; C Fréhel; C Offredo; E Skamene
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

5.  Induction of Mycobacterium avium gene expression following phagocytosis by human macrophages.

Authors:  G Plum; J E Clark-Curtiss
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

6.  Survival and replication of Rhodococcus equi in macrophages.

Authors:  M K Hondalus; D M Mosser
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

7.  Mycobacterium avium genes expressed during growth in human macrophages detected by selective capture of transcribed sequences (SCOTS).

Authors:  Joan Y Hou; James E Graham; Josephine E Clark-Curtiss
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

8.  Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages.

Authors:  Jimin Zhang; Franziska Leifer; Sasha Rose; Dung Yu Chun; Jill Thaisz; Tracey Herr; Mary Nashed; Jayanthi Joseph; Walter R Perkins; Keith DiPetrillo
Journal:  Front Microbiol       Date:  2018-05-16       Impact factor: 5.640

9.  Presence of Infected Gr-1intCD11bhiCD11cint Monocytic Myeloid Derived Suppressor Cells Subverts T Cell Response and Is Associated With Impaired Dendritic Cell Function in Mycobacterium avium-Infected Mice.

Authors:  Ketema Abdissa; Andreas Nerlich; Andreas Beineke; Nanthapon Ruangkiattikul; Vinay Pawar; Ulrike Heise; Nina Janze; Christine Falk; Dunja Bruder; Ulrike Schleicher; Christian Bogdan; Siegfried Weiss; Ralph Goethe
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.